TFX
Teleflex IncorporatedHealthcare · $5.5B market cap
Verdict
We can't put a fair value on TFX right now. The financial data we receive for it contains an obvious error (its cash-flow profit is more than 10× its reported profit for the same year). We'll value it once the data is corrected.
Business quality
0 of 5 clear the 10% bar. What are the Big Five?
Follow TFX
Track it on your watchlist and see the full analysis. Free.
Create a free accountSuperinvestors
3 of the investors we track hold TFX. In Q2 2026, 3 trimmed. Who we track
Seth Klarman
Baupost Group LLC · as of Q2 2026
$178.6M
1,409,000 shares
Abrams Bison Investments
Abrams Bison Investments · as of Q2 2026
$100.5M
793,000 shares
Richard Pzena
Pzena Investment Management · as of Q2 2026
$76.5M
603,206 shares
Moves in Q2 2026
Trimmed: Seth Klarman, Richard Pzena, Abrams Bison Investments
Insider activity
Since Sep 8, 2026: no open-market purchases and 2 other filings (stock awards, tax withholding and similar). Why purchases matter
Other filings
About Teleflex Incorporated
Teleflex Incorporated is a global medical technology company dedicated to designing, developing, manufacturing, and distributing single-use medical devices. These products are crucial for diagnostic and therapeutic procedures, particularly within critical care and surgical environments worldwide. Its comprehensive product portfolio includes: Vascular Access Solutions: Featuring the "Arrow" brand, these include…
Medical - Instruments & Supplies
Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works